178 research outputs found
Indian patient use of cancer euphemisms: Association with psychological outcomes and health behaviours
Objective: Euphemisms may be used to reduce the threat associated with the word âcancer.â Cancer may be particularly threatening in Indian culture due to the myths surrounding its cause and prognosis. This study explored the prevalence of euphemism use by Indian patients and the relationship among euphemism use and illness cognitions, affect, health behaviour, and spontaneous self-affirmation (a behaviour associated with dealing with threat).
Methods: In total, 350 cancer patients in India were recruited to take part in a study exploring patients' experiences of, and thoughts about, having an illness. They responded to a questionnaire measuring illness perceptions, coping strategies, anxiety, depression, health behaviours, and spontaneous self-affirmation. Patients were asked what words they used to describe their illness; euphemism users were those who used a euphemism (ie, non-medical term) as a first word.
Results: About 51% of patients used a euphemism as a first word. Those with less education, unskilled employment, a lower income, and more children were more likely to be euphemism users. Euphemism users reported (a) weaker illness perceptions (less personal control, greater reporting of symptoms, and less understanding of their condition), (b) less use of 3 of 14 coping strategies, (c) less likelihood of spontaneously self-affirming, and (d) fewer healthy eating days.
Conclusions: Euphemism use in patients was not related to distress but was related to negative illness perceptions and use of fewer coping strategies, suggesting that we need further study about the extent to which euphemisms signal issues in psychological adaptation to cancer diagnosis
Recommended from our members
Carbon nanotube-coated recombinant human surfactant protein D reduces cell viability in an ovarian cancer cell line, SKOV3, and modulates mTOR pathway and pro-inflammatory cytokine response
Copyright © 2022 The Authors. Nanoparticles such as carbon nanotubes (CNTs) have various clinical and diagnostic applications as utilised for imaging and drug delivery. Therapeutic proteins/peptides can be loaded on CNT coronas to specifically hit immune cells in overdrive or uncontrolled malignant cells. Previously, it was reported that a recombinant version of human surfactant protein D (rfhSP-D) containing trimeric C-type lectin domains induced apoptosis in several tumour cells/cell lines, including SKOV3, which is an ovarian tumour cell line. Solid-phase rfhSP-D coated on a microtiter plate is considerably more potent in inducing apoptosis in breast tumour cells. We have immobilised highly purified, endotoxin-free rfhSP-D on CNTs and assessed its antiproliferative effect on SKOV3 cells. Biotinylated rfhSP-D-CNTs were phagocytosed by SKOV3 cells, followed by apoptosis in a time-dependent manner. Gene expression analysis revealed compromised mTOR complex as a mechanism of apoptosis. When rfhSP-D-CNTs were added to a culture system of SKOV3 cells, it produced a highly proinflammatory immune response that is likely anti-tumorigenic. Thus, rfhSP-D-CNT seems a worthwhile nanocarrier for testing in vivo using an animal model of orthotopic ovarian cancer.This research was funded by the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, Riyadh, KSA, through the Research Funding Program (Grant No# FRP-1440-27)
A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation, Th2 and B Cell Responses in Grass Pollen-induced Allergic Inflammation
Rationale: rfhSP-D has been shown to suppress house dust mite and Aspergillus
74 fumigatus-induced allergic inflammation in murine models.
75 Objectives: We sought to elucidate the effect of rfhSP-D on FcΔRI and CD23-
76 mediated grass pollen induced allergic inflammatory responses.
77 Methods: rfhSP-D, containing homotrimeric neck and lectin domains, was
78 expressed in Escherichia coli BL21 (λDE3) pLysS. PBMCs and sera were obtained
79 from grass pollen allergic individuals (n=27). The effect of rfhSP-D on basophil
80 activation and histamine release was measured by flow cytometry. IgE-facilitated
81 allergen binding and presentation was assessed by flow cytometry. Th2 cytokines
82 were measured in cell culture supernatants. The effect of rfhSP-D on IgE production
83 by B cells when stimulated with CD40L, IL-4 and IL-21 was also determined.
84 Results: rfhSP-D bound to Phleum pratense in a dose- and calcium-dependent
85 manner. Allergen-induced basophil responsiveness and histamine release was
86 inhibited in the presence of rfhSP-D, as measured by CD63, CD203c
87 (P=0.0086,P=0.04205), and intracellular-labelled DAO (P=0.0003,P=0.0148). The
88 binding of allergen-IgE complexes to B cells was reduced by 51%(P=0.002) in the
89 presence of rfhSP-D. This decrease was concomitant with reduction in CD23
90 expression on B cells (P<0.001). rfhSP-D suppressed allergen-driven CD27-
91 CD4+CRTH2+ T cell proliferation (P<0.01), IL-4 and IL-5 levels (all, P<0.01).
92 Moreover, rfhSP-D inhibited CD40L/IL-4 and IL-21-mediated IgE production(77.12%;
93 P=0.02) by B cells.
94 Conclusion: For the first time, we show that rfhSP-D inhibited allergen-induced
95 basophil responses at a single cell, level and suppressed CD23-mediated facilitated
5
allergen presentation and Th2 cytokine production. 96 In addition, rfhSP-D inhibited IgE
97 synthesis by B cells, which is also a novel observation.This research was funded by Royal Brompton Hospital charity research funds
Placental Vesicles Carry Active Endothelial Nitric Oxide Synthase and Their Activity is Reduced in Preeclampsia.
Preeclampsia (PE), a multi-system hypertensive disorder of pregnancy, is associated 25 with increased systemic vascular resistance. Placentae from PE patients have 26 reduced levels of endothelial nitric oxide synthase (eNOS) and thus less nitric oxide 27 (NO). Syncytiotrophoblast extracellular vesicles (STBEV), comprised of microvesicles 28 (STBMV) and exosomes (STBEX), carry signals from the STB to the mother. We 29 hypothesized that STBEV bound eNOS (STBEV-eNOS), capable of producing NO, 30 are released into the maternal circulation. Dual-lobe ex vivo placental perfusion and 31 differential centrifugation was used to isolate STBEV from PE (n=8) and normal 32 pregnancies (NP) (n=11). Plasma samples of gestational age matched PE and NP 33 (n=6) were used to isolate circulating STBMV. STBEV expressed placental alkaline 34 phosphatase (PlAP), confirming placental origin. STBEV co-expressed eNOS, but not 35 iNOS, confirmed using Western blot, flow cytometry and immuno-depletion. STBEV-36 eNOS produced NO which was significantly inhibited by L-NAME (eNOS inhibitor, 37 *p<0.05), but not 1400W (iNOS inhibitor). STBEV-eNOS catalytic activity was 38 confirmed by visualising eNOS dimerization. STBEV-eNOS was more abundant in 39 uterine vein compared to peripheral blood, indicating placental origin. STBEV isolated 40 from PE perfused placentae had lower levels of STBEV-eNOS (STBMV; *p<0.05) and 41 overall lower NO activity (STBMV, ns; STBEX, *p<0.05) compared to NP. Circulating 42 plasma STBMV from PE women had lower STBEV-eNOS expression compared to NP 43 women (**p<0.01). This is the first observation of functional eNOS expressed on 44 STBEV from NP and PE placentae, as well as in plasma. The lower STBEV-eNOS 45 NO production seen in PE may contribute to the decreased NO bioavailability in this 46 disease
Drug-Eluting Stents in Patients with Chronic Kidney Disease: A Prospective Registry Study
BACKGROUND: Chronic kidney disease (CKD) is strongly associated with adverse outcomes after percutaneous coronary intervention (PCI). There are limited data on the effectiveness of drug-eluting stents (DES) in patients with CKD. METHODOLOGY/PRINCIPAL FINDINGS: Of 3,752 consecutive patients enrolled in the Guthrie PCI Registry between 2001 and 2006, 436 patients with CKD - defined as a creatinine clearance <60 mL/min - were included in this study. Patients who received DES were compared to those who received bare metal stents (BMS). Patients were followed for a mean duration of 3 years after the index PCI to determine the prognostic impact of stent type. Study end-points were all-cause death, myocardial infarction (MI), target vessel revascularization (TVR), stent thrombosis (ST) and the composite of major adverse cardiovascular events (MACE), defined as death, MI or TVR. Patients receiving DES in our study, by virtue of physician selection, had more stable coronary artery disease and had lower baseline risk of thrombotic or restenotic events. Kaplan-Meier estimates of proportions of patients reaching the end-points were significantly lower for DES vs. BMS for all-cause death (pâ=â0.0008), TVR (pâ=â0.029) and MACE (pâ=â0.0015), but not MI (pâ=â0.945) or ST (pâ=â0.88). Multivariable analysis with propensity adjustment demonstrated that DES implantation was an independent predictor of lower rates of all-cause death (hazard ratio [HR] 0.48, 95% confidence interval [CI] 0.25-0.92), TVR (HR 0.50, 95% CI 0.27-0.94) and MACE (HR 0.62, 95% CI 0.41-0.94). CONCLUSIONS: In a contemporary PCI registry, selective use of DES in patients with CKD was safe and effective in the long term, with lower risk of all-cause death, TVR and MACE and similar risk of MI and ST as compared with BMS. The mortality benefit may be a result of selection bias and residual confounding, or represent a true finding; a hypothesis that warrants clarification by randomized clinical trials
Fungal Virulence and Development Is Regulated by Alternative Pre-mRNA 3âČEnd Processing in Magnaporthe oryzae
RNA-binding proteins play a central role in post-transcriptional mechanisms that control gene expression. Identification of novel RNA-binding proteins in fungi is essential to unravel post-transcriptional networks and cellular processes that confer identity to the fungal kingdom. Here, we carried out the functional characterisation of the filamentous fungus-specific RNA-binding protein RBP35 required for full virulence and development in the rice blast fungus. RBP35 contains an N-terminal RNA recognition motif (RRM) and six Arg-Gly-Gly tripeptide repeats. Immunoblots identified two RBP35 protein isoforms that show a steady-state nuclear localisation and bind RNA in vitro. RBP35 coimmunoprecipitates in vivo with Cleavage Factor I (CFI) 25 kDa, a highly conserved protein involved in polyA site recognition and cleavage of pre-mRNAs. Several targets of RBP35 have been identified using transcriptomics including 14-3-3 pre-mRNA, an important integrator of environmental signals. In Magnaporthe oryzae, RBP35 is not essential for viability but regulates the length of 3âČUTRs of transcripts with developmental and virulence-associated functions. The Îrbp35 mutant is affected in the TOR (target of rapamycin) signaling pathway showing significant changes in nitrogen metabolism and protein secretion. The lack of clear RBP35 orthologues in yeast, plants and animals indicates that RBP35 is a novel auxiliary protein of the polyadenylation machinery of filamentous fungi. Our data demonstrate that RBP35 is the fungal equivalent of metazoan CFI 68 kDa and suggest the existence of 3âČend processing mechanisms exclusive to the fungal kingdom
Metaheuristics for Transmission Network Expansion Planning
This chapter presents the characteristics of the metaheuristic algorithms used to solve the transmission network expansion planning (TNEP) problem. The algorithms used to handle single or multiple objectives are discussed on the basis of selected literature contributions. Besides the main objective given by the costs of the transmission system infrastructure, various other objectives are taken into account, representing generation, demand, reliability and environmental aspects. In the single-objective case, many metaheuristics have been proposed, in general without making strong comparisons with other solution methods and without providing superior results with respect to classical mathematical programming. In the multi-objective case, there is a better convenience of using metaheuristics able to handle conflicting objectives, in particular with a Pareto front-based approach. In all cases, improvements are still expected in the definition of benchmark functions, benchmark networks and robust comparison criteria
Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-ÎșB Inhibitors in Ovarian Cancer Therapy
Several epidemiological studies have correlated the use of non-steroidal anti-inflammatory drugs (NSAID) with reduced risk of ovarian cancer, the most lethal gynecological cancer, diagnosed usually in late stages of the disease. We have previously established that the pro-apoptotic cytokine melanoma differentiation associated gene-7/Interleukin-24 (mda-7/IL-24) is a crucial mediator of NSAID-induced apoptosis in prostate, breast, renal and stomach cancer cells. In this report we evaluated various structurally different NSAIDs for their efficacies to induce apoptosis and mda-7/IL-24 expression in ovarian cancer cells. While several NSAIDs induced apoptosis, Sulindac Sulfide and Diclofenac most potently induced apoptosis and reduced tumor growth. A combination of these agents results in a synergistic effect. Furthermore, mda-7/IL-24 induction by NSAIDs is essential for programmed cell death, since inhibition of mda-7/IL-24 by small interfering RNA abrogates apoptosis. mda-7/IL-24 activation leads to upregulation of growth arrest and DNA damage inducible (GADD) 45 α and Îł and JNK activation. The NF-ÎșB family of transcription factors has been implicated in ovarian cancer development. We previously established NF-ÎșB/IÎșB signaling as an essential step for cell survival in cancer cells and hypothesized that targeting NF-ÎșB could potentiate NSAID-mediated apoptosis induction in ovarian cancer cells. Indeed, combining NSAID treatment with NF-ÎșB inhibitors led to enhanced apoptosis induction. Our results indicate that inhibition of NF-ÎșB in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer
- âŠ